Christopher Peetz - Jan 31, 2023 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
President and CEO, Director
Signature
/s/ Jody Howe, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Jan 31, 2023
Transactions value $
$0
Form type
4
Date filed
2/2/2023, 04:39 PM
Previous filing
Mar 18, 2024
Next filing
May 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $0 +50K +71.86% $0.00 120K Jan 31, 2023 Direct F1
holding MIRM Common Stock 202K Jan 31, 2023 By The Peetz Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Award $0 +200K $0.00 200K Jan 31, 2023 Common Stock 200K $23.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
F2 1/4th of the shares vest one year after January 31, 2023 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.